SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.210.0%9:46 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Perry who wrote (2204)5/7/1998 1:22:00 PM
From: Anthony Wong  Read Replies (2) of 9523
 
Perry, here's the excerpt from today's London Times:

BTP, the chemicals company, was the star performer.
Dealers are beginning to re-evaluate the impact of its
contract to supply chemicals used in Viagra, Pfizer's
"magic bullet" treatment for male impotence. Its shares
jumped 29p to 475p on news that the drug, available for
œ16 only on prescription in the UK, is already out-selling
Prozac in some US states after being on sale for less than
two months.

There are also rumours that Pfizer is close to securing
regulatory approval to sell the drug over the counter in the
UK.


My interpretation is that it is outselling Prozac now in some states, doesn't mean the total prescription number is higher than that for Prozac.

If it is sold over the counter in the UK, watch for the demand. It's easy for people from other European countrires to go to the UK to get the pills rather than et it in their own country with a prescription.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext